Abstract:Polycomb group (PcG) proteins have recently been shown related to cancer development. The PcG protein EZH2 is involved in progression of prostate and breast cancers, and has been identified as a molecular marker in breast cancer. Nevertheless, the molecular mechanism by which PcG proteins regulate cancer progression and malignant metastasis is still unclear. PcG proteins methylate H3K27 in undifferentiated epithelial cells, resulting in the repression of differentiation genes such as HOX. FOXC1 is a member of the Forkhead box transcription factor family, which plays an important role in differentiation, and is involved in eye development. We discovered in this study that the expression of FOXC1 gene was negatively correlated to that of PcG genes, i.e., Bmi1, EZH2, and SUZ12, in MCF-7 and MDAMB-231 cells. To investigate the regulatory effects of PcG proteins on FOXC1 gene, the two cell lines were transfected with either expression plasmids or siRNA plasmids of Bmi1, EZH2, and SUZ12, and we found that PcGs, especially EZH2, could repress the transcription of FOXC1 gene. Chromatin immunoprecipitation (ChIP) assay showed that histone methylation and acetylation modifications played critical roles in this regulatory process. When FOXC1 was stably transfected into MDA-MB-231 cells, the migration and invasion of the cells were repressed. Moreover, the tumorigenicity and the spontaneous metastatic capability regulated by FOXC1 were determined by using an orthotropic xenograft tumor model of athymic mice with the FOXC1-MDA-MB231HM and the GFP-MDA-MB-231HM cells, and the results showed that FOXC1 in MDA-MB-231HM cells inhibited migration and invasion in vitro and reduced the pulmonary metastasis in vivo. Data presented in this report contribute to the understanding of the mechanisms by which EZH2 participates in tumor development.

FOXC 1 , a Target of Polycomb , Inhibits Metastasis of Breast Cancer Cells

FOXN Transcription Factors: Regulation and Significant Role in Cancer

FOXN Transcription Factors: Regulation and Significant Role in Cancer.

FOXA2-Interacting FOXP2 Prevents Epithelial-Mesenchymal Transition of Breast Cancer Cells by Stimulating E-Cadherin and PHF2 Transcription

p38-regulated FOXC1 stability is required for colorectal cancer metastasis.

Contribution of Foxc1 to the Progression and Metastasis and Prognosis of Human Colon Cancer.

EZH2 regulates expression of FOXC1 by mediating H3K27me3 in breast cancers

FOXC2 Promotes Oxaliplatin Resistance by Inducing Epithelial-Mesenchymal Transition via MAPK/ERK Signaling in Colorectal Cancer

Overexpression of Forkhead Box L1 (FOXL1) Inhibits the Proliferation and Invasion of Breast Cancer Cells.

FOXO1 Negates the Cooperative Action of FOXL2C134W and SMAD3 in CYP19 Expression in HGrC1 Cells by Sequestering SMAD3

Downregulation of FOXP2 Promotes Breast Cancer Migration and Invasion Through TGFβ/SMAD Signaling Pathway

FoxO1 Promotes Ovarian Cancer by Increasing Transcription and METTL14-mediated M6a Modification of SMC4

FOXC1 Contributes to Microvascular Invasion in Primary Hepatocellular Carcinoma Via Regulating Epithelial-Mesenchymal Transition

FOXQ1 recruits the MLL complex to activate transcription of EMT and promote breast cancer metastasis

Quantitative Proteomic Analysis Identifies New Effectors of FOXM1 Involved in Breast Cancer Cell Migration.

FOXA1 Leads to Aberrant Expression of SIX4 Affecting Cervical Cancer Cell Growth and Chemoresistance

The FOXC1/FBP1 Signaling Axis Promotes Colorectal Cancer Proliferation by Enhancing the Warburg Effect

Transcription factor FOXF2 promotes the development and progression of pancreatic cancer by targeting MSI2

Overexpression of Forkhead Box C2 Promotes Tumor Metastasis and Indicates Poor Prognosis in Colon Cancer Via Regulating Epithelial-Mesenchymal Transition.

The FOXC1/FBP1 Signaling Axispromotes Tumorigenicity by Enhancing the Warburg Effect in Colorectal Cancer.

Research progress on the forkhead box C1.